A carregar...
Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
The application of nanoparticle drug formulations, such as nanoliposomal doxorubicin (Doxil), is increasingly integrated in clinical cancer care. Despite nanomedicine's remarkable potential and growth over the last three decades, its clinical benefits for cancer patients vary. Here we report a...
Na minha lista:
| Publicado no: | Nat Commun |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4915130/ https://ncbi.nlm.nih.gov/pubmed/27319780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms11838 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|